A new phase 1 randomized controlled trial finds that a single dose of the ChAdox1 Rift Valley fever (RVF) vaccine appears ...

Winter's chill invites comforting spices that offer more than just flavor. Cinnamon, black pepper, turmeric, cardamom, nuts, ...

Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...

Data presented at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting The spliceosome targeting payload, PH1, ...

In preclinical experiments, the combination of Trastuzumab PH1 + anti-PD1 outperforms the combination of Kadcyla® + anti-PD1 with a statistically significantly greater rate of Complete Responses (74% ...

IAVI reports its single-dose Lassa fever vaccine is safe and effective, paving way for advanced trials across West Africa.

Volunteers were monitored for 12 months post-vaccination, with immune responses activating both humoral and cellular immunity ...

A Lassa fever vaccine candidate was safe and produced a strong immune response in adults in the United States and Liberia, ...

Felzartamab, an investigational anti-CD38 monoclonal antibody, is a potentially differentiated therapeutic candidate with promise for a broad range of immune-mediated diseases ...

Nicole Charky-Chami is a senior editor based in Los Angeles, writing and producing breaking news. She teaches journalism courses for UCLA Extension and previously taught at Loyola Marymount University ...

Please provide your email address to receive an email when new articles are posted on . There were no serious bacterial infections or hospitalizations due to infection over 12 months among adults ...

ABSTRACT: Food quality is one of the most important factors influencing animals’ immunity. In the present study, Siberian hamsters (Phodopus sungorus) were used to understand the effect of feeding ...